Assessment Prevalence of Thrombocytopenia in Chronic Hepatitis B and C
DOI:
https://doi.org/10.51699/ijhsms.v3i3.3571Keywords:
CLD, HCV, HBV, ThrombocytopeniaAbstract
Thrombocytopenia is a common complication in chronic liver disease characterized by a low platelet count, which is lower than the normal platelet count < 150 X10 9. The condition had variable incidence, regarding viral hepatitis and is more common in hepatitis C than B. Aim of the study: Assess the prevalence of thrombocytopenia (lower than normal platelet count) in patients proved to have hepatitis B and C by RNA testing. Cross sectional study included 50 viral hepatitis patients (HCV and HBV diagnosed previously), all patients were evaluated for complete blood count and liver function test. Males were forming 68% of all participant, 58% were HBV patients and 42% were HCV patients. The overall prevalence of Thrombocytopenia was 46%. The mean platelet level in HCV was177.43 ± 18.19 with higher prevalence of thrombocytopenia (60.9% vs 39.1%) in hepatitis C than B, with no association between gender and liver functions. Thrombocytopenia one of common complications in viral hepatitis, despite that both HCV and HBV had lower platelet count in comparison to normal person, the count is much more lower in HCV patients with higher prevalence of thrombocytopenia in compare to HBV that is more common in male gender.
Downloads
References
Beasley, R. P., Hwang, L. Y., Lin, C. C., Leu, M. L., Stevens, C. E., Szmuness, W., & Chen, K. P. (1982). Incidence of hepatitis B virus infections in preschool children in Taiwan. The Journal of infectious diseases, 146(2), 198–204. https://doi.org/10.1093/infdis/146.2.198
Beasley, R., Hwang, L.-Y., Lin, C.-C., Leu, M.-L., Stevens, C., Szmuness, W., & Chen, K.-P. (1982). Incidence of hepatitis B virus infections in preschool children in Taiwan. The Journal of infectious diseases, 146(2), 198-204.
Borgia, S. M., Hedskog, C., Parhy, B., Hyland, R. H., Stamm, L. M., Brainard, D. M., ... & Shafran, S. D. (2018). Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. The Journal of infectious diseases, 218(11), 1722-1729
Borgia, S. M., Hedskog, C., Parhy, B., Hyland, R. H., Stamm, L. M., Brainard, D. M., Subramanian, M. G., McHutchison, J. G., Mo, H., & Svarovskaia, E. (2018). Identification of a novel hepatitis C virus genotype from Punjab, India: expanding classification of hepatitis C virus into 8 genotypes. The Journal of infectious diseases, 218(11), 1722-1729.
Burns, G. S., & Thompson, A. J. (2014). Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harbor perspectives in medicine, 4(12), a024935. https://doi.org/10.1101/cshperspect.a024935
Burns, G. S., & Thompson, A. J. (2014). Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harbor perspectives in medicine, 4(12), a024935.
Chisari, F. V., Isogawa, M., & Wieland, S. F. (2010). Pathogenesis of hepatitis B virus infection. Pathologie-biologie, 58(4), 258–266. https://doi.org/10.1016/j.patbio.2009.11.001
Dunn, R., Wetten, A., McPherson, S., & Donnelly, M. C. (2022). Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World journal of gastroenterology, 28(1), 76.
El‐Serag, H. B. (2020). Epidemiology of hepatocellular carcinoma. The liver: Biology and pathobiology, 758-772.
Falla, A. M., Hofstraat, S. H. I., Duffell, E., Hahné, S. J. M., Tavoschi, L., & Veldhuijzen, I. K. (2018). Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC infectious diseases, 18(1), 1-12
Falla, A. M., Hofstraat, S. H. I., Duffell, E., Hahné, S. J. M., Tavoschi, L., & Veldhuijzen, I. K. (2018). Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC infectious diseases, 18, 1-12.
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., ... & Kaldor, J. M. (2001). Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology, 34(4), 809-816
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001). Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology, 34(4), 809-816.
Gotlieb, N., Schwartz, N., Zelber-Sagi, S., Chodick, G., Shalev, V., & Shibolet, O. (2020). Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World Journal of Gastroenterology, 26(38), 5849.
Gotlieb, N., Schwartz, N., Zelber-Sagi, S., Chodick, G., Shalev, V., & Shibolet, O. (2020). Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World journal of gastroenterology, 26(38), 5849.
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., ... & Ryerson, A. B. (2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013‐2016. Hepatology, 69(3), 1020-1031
Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013‐2016. Hepatology, 69(3), 1020-1031.
Hong, T. P. (2019). An Australian population-based study of the incidence and outcomes of hepatocellular carcinoma: the hepatomas of melbourne epidemiological research (homer) study (Doctoral dissertation).
Houot, M., Ngo, Y., Munteanu, M., Marque, S., & Poynard, T. (2016). Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Alimentary pharmacology & therapeutics, 43(1), 16-29.
Houot, M., Ngo, Y., Munteanu, M., Marque, S., & Poynard, T. (2016). Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Alimentary pharmacology & therapeutics, 43(1), 16-29.
Huang, C. E., Chang, J. J., Wu, Y. Y., Huang, S. H., Chen, W. M., Hsu, C. C., ... & Chen, M. C. (2021). Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. Biomedical journal.
Huang, C.-E., Chang, J.-J., Wu, Y.-Y., Huang, S.-H., Chen, W.-M., Hsu, C.-C., Lu, C.-H., Hung, C.-H., Shi, C.-S., & Lee, K.-D. (2022). Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. biomedical journal, 45(5), 788-797.
Huang, N. E. (2014). Introduction to the Hilbert–Huang transform and its related mathematical problems. In Hilbert–Huang transform and its applications (pp. 1-26). World Scientific.
Jahangiri, A. (2022). Molecular mechanisms that control platelet receptors in people with thrombocytopenia The Australian National University (Australia)].
Kim, D., Touros, A., & Kim, W. R. (2018). Nonalcoholic fatty liver disease and metabolic syndrome. Clinics in liver disease, 22(1), 133-140.
Kim, D., Touros, A., & Kim, W. R. (2018). Nonalcoholic fatty liver disease and metabolic syndrome. Clinics in liver disease, 22(1), 133-140.
Kowdley, K. V., Wang, C. C., Welch, S., Roberts, H., & Brosgart, C. L. (2012). Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology (Baltimore, Md.), 56(2), 422–433. https://doi.org/10.1002/hep.24804
Kowdley, K. V., Wang, C. C., Welch, S., Roberts, H., & Brosgart, C. L. (2012). Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin. Hepatology, 56(2), 422-433.
Liu, Z., Shi, O., Zhang, T., Jin, L., & Chen, X. (2020). Disease burden of viral hepatitis A, B, C and E: a systematic analysis. Journal of viral hepatitis, 27(12), 1284-1296.
Meintker, L., & Krause, S. W. (2020). Reticulated platelets–clinical application and future perspectives. Journal of Laboratory Medicine, 44(5), 241-253.
Meintker, L., & Krause, S. W. (2020). Reticulated platelets–clinical application and future perspectives. Journal of Laboratory Medicine, 44(5), 241-253.
Mitchell, O., Feldman, D. M., Diakow, M., & Sigal, S. H. (2016). The pathophysiology of thrombocytopenia in chronic liver disease. Hepatic medicine: evidence and research, 8, 39.
Mitchell, O., Feldman, D. M., Diakow, M., & Sigal, S. H. (2016). The pathophysiology of thrombocytopenia in chronic liver disease. Hepatic medicine: evidence and research, 39-50.
Moore, A. H. (2019). Thrombocytopenia in cirrhosis: A review of pathophysiology and management options. Clinical Liver Disease, 14(5), 183.
Moore, A. H. (2019). Thrombocytopenia in cirrhosis: a review of pathophysiology and management options. Clinical liver disease, 14(5), 183-186.
Ocama, P., Opio, C. K., & Lee, W. M. (2005). Hepatitis B virus infection: current status. The American journal of medicine, 118(12), 1413-e15.
Ocama, P., Opio, C. K., & Lee, W. M. (2005). Hepatitis B virus infection: current status. The American journal of medicine, 118(12), 1413. e1415-1413. e1422.
Omar, A. S., Elhadidi, A. S., Zaki, N. E., & Tawfik, R. H. (2014). Antiplatelet antibodies in chronic hepatitis C patients: correlation with platelet count and viral load. The Egyptian Journal of Haematology, 39(3), 114.
Omar, A. S., Elhadidi, A. S., Zaki, N. E., & Tawfik, R. H. (2014). Antiplatelet antibodies in chronic hepatitis C patients: correlation with platelet count and viral load. The Egyptian Journal of Haematology, 39(3), 114-121.
Peck‐Radosavljevic, M. (2017). Thrombocytopenia in chronic liver disease. Liver International, 37(6), 778-793.
Peck‐Radosavljevic, M. (2017). Thrombocytopenia in chronic liver disease. Liver International, 37(6), 778-793.
Rawi, S., & Wu, G. Y. (2020). Pathogenesis of thrombocytopenia in chronic HCV infection: a review. Journal of Clinical and Translational Hepatology, 8(2), 184.
Rawi, S., & Wu, G. Y. (2020). Pathogenesis of thrombocytopenia in chronic HCV infection: a review. Journal of clinical and translational hepatology, 8(2), 184.
Saiyed, M., Byrnes, J., Srivastava, T., Scuffham, P., & Downes, M. (2020). Cost-effectiveness of lenvatinib compared with sorafenib for the first-line treatment of advanced hepatocellular carcinoma in Australia. Clinical Drug Investigation, 40, 1167-1176.
Scharf, R. E. (2021). Thrombocytopenia and hemostatic changes in acute and chronic liver disease:
Pathophysiology, clinical and laboratory features, and management. Journal of Clinical Medicine, 10(7), 1530.
Scharf, R. E. (2021). Thrombocytopenia and hemostatic changes in acute and chronic liver disease: pathophysiology, clinical and laboratory features, and management. Journal of Clinical Medicine, 10(7), 1530.
Sharma, A., & Nagalli, S. (2020). Chronic liver disease. StatPearls [Internet]
Sharma, A., & Nagalli, S. (2023). Chronic liver disease. In StatPearls [Internet]. StatPearls Publishing.
Shashidhar, K. N., & Nallagangula, K. S. (2019). Pros and Cons of Existing Biomarkers for Cirrhosis of Liver. Acta Scientific Medical Sciences, 3, 63-72.
Shashidhar, K., & Nallagangula, K. S. (2019). Pros and cons of existing biomarkers for cirrhosis of liver. Acta Scientific Medical Sciences, 3(6), 63-72.
Terrault, N. A., Lok, A. S., McMahon, B. J., Chang, K. M., Hwang, J. P., Jonas, M. M., Brown Jr, R. S., Bzowej, N. H., & Wong, J. B. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560-1599.
Terrault, N. A., Lok, A., McMahon, B. J., Chang, K. M., Hwang, J. P., Jonas, M. M., Brown, R. S., Jr, Bzowej, N. H., & Wong, J. B. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology (Baltimore, Md.), 67(4), 1560–1599. https://doi.org/10.1002/hep.29800
Torre, P., Aglitti, A., Masarone, M., & Persico, M. (2021). Viral hepatitis: Milestones, unresolved issues, and future goals. World Journal of Gastroenterology, 27(28), 4603
Torre, P., Aglitti, A., Masarone, M., & Persico, M. (2021). Viral hepatitis: Milestones, unresolved issues, and future goals. World journal of gastroenterology, 27(28), 4603.
Vogel, A., Cervantes, A., Chau, I., Daniele, B., Llovet, J. M., Meyer, T., Nault, J.-C., Neumann, U., Ricke, J., & Sangro, B. (2018). Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 29, iv238-iv255.
Wiese, M., Grüngreiff, K., Güthoff, W., Lafrenz, M., Oesen, U., & Porst, H. (2005). Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study. Journal of hepatology, 43(4), 590-598.
World Health Organization. Hepatitis C. [cited 11 April 2021]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
Yoshida, M., Tateishi, R., Hiroi, S., Fujiwara, M., Kitanishi, Y., Iwasaki, K., ... & Igarashi, A. (2022). Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data. Advances in therapy, 39(2), 992-1003.
Yoshida, M., Tateishi, R., Hiroi, S., Fujiwara, M., Kitanishi, Y., Iwasaki, K., Takeshima, T., & Igarashi, A. (2022). Changes in platelet counts and thrombocytopenia risk in patients with chronic liver disease with different etiologies using real-world Japanese data. Advances in therapy, 1-12.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ali Kareem Durib, Zainab Ahmad Hassan, Zainab Ahmad Hassan, Zorkin Michael Viktorovich
This work is licensed under a Creative Commons Attribution 4.0 International License.
